Back to 
Farallon Capital Management, L.L.C.
Farallon Capital Management, L.L.C.
IOVA
Showing 8 of 27 quarters
Position history for Farallon Capital Management, L.L.C.'s holdings in Iovance Biotherapeutics, Inc.
No. Farallon Capital Management exited its IOVA (Iovance Biotherapeutics) position in Q2 2026. Its Q1 2026 13F listed 26,000 shares worth $91,260. Farallon Capital Management already held IOVA in its Q4 2018 13F, the earliest on record, and held it in 25 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$244,140
Total Shares Change
-26,000
Quarter-by-Quarter History